Epilepsy, Epilepsy Intractable
Conditions
Keywords
Refractory Epilepsy, Green Light Exposure, Epileptic Spikes
Brief summary
The purpose of this study is to obtain preliminary data in advance of a larger clinical trial aimed to test whether a single session of green light exposure can lead to a clinically significant reduction in epileptic spikes in patients with medically-refractory epilepsy. As this is a potentially fragile patient population, the study will test safety and tolerability as well as efficacy.
Detailed description
The trial is designed to detect (1) change in spike frequency on EEG before and after exposure to low intensity green light, and (2) presence or absence of neurologic/systemic symptoms referable to exposure of the pre-selected duration, intensity, and band of green light. Our primary aim is to determine whether prolonged exposure (120 minutes) to a narrow band of green light (520-540 nm) at low intensities (1-10 cd/m2) alters the pattern of electrical activity in the cortex of epilepsy patients. The primary outcome measure for this aim will be the fraction of patients in which the number of epileptiform discharges (spikes or sharp waves) decrease, per recording, in response to green light exposure, as determined by spike frequency detected via scalp EEG before and after green light exposure. The investigators anticipate that the primary outcome measures of safety and tolerability will not differ from the previously established measures of green light exposure for migraine (Noseda et al. 2016). The investigators will use only low intensities (1-10 cd/m2) of green light which is well tolerated in adults and children (Main et al. 2000). In addition, given limited experience with conventional green light exposure in epilepsy, the investigators predict that post-exposure to green light, patients will have an improvement on the post-exposure EEG (decreased spike frequency).
Interventions
DEVICEGreen Light Exposure
To test whether exposure to a narrow band of green light (520-540 nm) at low intensities (1-10 cd/m2) decreases interictal epileptiform discharges in patients with epilepsy. The overall hypothesis for this open-label trial is based on findings in patients with migraine that indicate an engagement of thalamocortical inhibitory circuits by green light.
Sponsors
Boston Children's Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
This is a single-center, open label, pilot feasibility study.
Eligibility
Sex/Gender
ALL
Age
6 Months to 30 Years
Healthy volunteers
No
Inclusion criteria
* 6 months-30 years of age * Epileptic spike frequency ≥1 epileptic spike per minute at baseline, as determined by scalp EEG recording * Admitted to the Boston Children's Hospital Epilepsy Long Term Monitoring Unit at the time of enrollment
Exclusion criteria
* Cataracts * Retinol disease * Any history of or currently not well controlled ophthalmic disease that prevents transmission from the retina to the optic nerve * Clinical seizure 4 hours or less before anticipated green light exposure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Effects of exposure to a narrow band of green light (520-540 nm) at low intensities (1-10 cd/m2) on the pattern of electrical activity in the cortex of epilepsy patients. | 120 minutes | The primary outcome measure for this aim will be the fraction of patients in which the number of epileptiform discharges (spikes or sharp waves) decrease, per recording, in response to green light exposure, as determined by spike frequency detected via scalp EEG before and after green light exposure. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| To consider probable confounders, such as etiology and comorbidities, this information will be acquired with standardized NIH epilepsy data acquisition forms for (1): | 10 minutes | Additional anticipated variable (1) patient demographics (age, gender, age of seizure onset, and epilepsy type), will be collected via a 'Demographics' Form. |
| To consider probable confounders, such as etiology and comorbidities, this information will be acquired through routine clinical care documentation by the study MD for (2): | 10 minutes | Additional anticipated variable (2) EEG monitoring findings: The study MD will review prior clinical EEG findings per participant. |
| To consider probable confounders, such as etiology and comorbidities, this information will be acquired through routine clinical care documentation by the study MD for (3): | 10 minutes | Additional anticipated variable (3) Imaging results: The study MD will review prior clinical imaging findings per participant. |
Countries
United States
Contacts
Primary ContactPaul MacMullin
Backup ContactMelissa DiBacco, MD
Outcome results
None listed